Emerald Therapeutics, Inc. is a biotechnology company based in South San Francisco, California, focused on advancing the field of gene therapy. The organization specializes in developing innovative solutions for genetic disorders through its proprietary platform that enables precise and efficient gene editing. By leveraging cutting-edge technologies, Emerald Therapeutics aims to address unmet medical needs and improve patient outcomes in various therapeutic areas, including rare diseases and other genetic conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

10 Patents

#105 in South San Francisco, CA

#7,134 in California

#29,944 in US

#56,228 in the World

South San Francisco, CA, United States of America

Emerald Therapeutics, Inc.

Forward Citations = 15

13 inventors:

Daniel J Kleinbaum (10 out of 13 patents)

Brian M Frezza (8 out of 11 patents)

George W Fraser (6 out of 9 patents)

4. Jonathan K Leung (6 out of 9 patents)

5. Brad Bond (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Emerald Therapeutics, Inc.. Retrieved from https://idiyas.com/company/emerald-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]